First test in humans: scientists check safety of new drug
NCT ID NCT05076422
Summary
This was an early-stage study to check the safety and see how the body processes a new drug called BI 3006337. It involved 80 healthy male volunteers who received a single injection. The main goal was to find out what side effects might occur and to measure how much of the drug gets into the blood and how long it stays there.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ICON
Groningen, 9728 NZ, Netherlands
-
SGS Life Science Services - Clinical Research
Edegem, 2650, Belgium
Conditions
Explore the condition pages connected to this study.